24 November 2020 : Original article
Role of Renal Replacement Therapy During the Peri-Transplant Period of Heart Transplantation
Sua Lee1ABCDEF, Tae Hyun Ban2ABCDEF*, Hoon Suk Park2BF, Suk Min Seo3EF, Byung Ha Chung45CF, Jihyang Lim6EF, Eun-Jee Oh7BC, Bumsoon Choi2EF, Cheol Whee Park4EF, Chul Woo Yang45CDE, Sang Hong Baek8DE, Yong-Soo Kim4EFDOI: 10.12659/AOT.925648
Ann Transplant 2020; 25:e925648
Supplementary Table 1 Basic demographics of patients in HF with HT and HF without HT.
| Variables | HF with HT (n=21) | HF without HT (n=35) | P value |
|---|---|---|---|
| Age (years), mean±SD | 43.4±14.6 | 62.1±10.3 | |
| Gender, Male, n (%) | 18 (85.7) | 29 (82.9) | 1.000 |
| Follow-up duration (months), median (IQR) | 16.0 (6.0, 77.1) | 12.4 (6.9, 27.9) | 0.234 |
| Comorbidity | 0.943 | ||
| HTN, n (%) | 4 (19.0) | 14 (40.0) | |
| DM, n (%) | 8 (38.1) | 15 (42.9) | |
| CAD, n (%) | 10 (47.6) | 9 (25.7) | |
| MI, n (%) | 8 (38.1) | 7 (20.0) | |
| Underlying cardiac disease, n (%) | |||
| DCMP | 11 (52.4) | 4 (11.4) | |
| ICMP | 9 (42.9) | 29 (82.9) | |
| Others | 1 (4.8) | 2 (5.7) | 1.000 |
| LVEF at time of admission (%), mean±SD | 21.7±9.2 | 28.7±12.4 | |
| Baseline serum Cr (mg/dL), mean±SD | 1.1±0.5 | 1.1±0.4 | 0.905 |
| Baseline CKD-EPI eGFR (ml/min/1.73 m), mean±SD | 88.2±32.8 | 78.1±25.5 | 0.207 |
| Serum Cr on 1 day before HT or ECMO (mg/dL), mean±SD | 1.9±1.1* | 1.7±0.8* | 0.735 |
| CKD-EPI eGFR on 1 day before HT or ECMO (ml/min/1.73 m), mean±SD | 62.2±47.8* | 49.7±24.4* | 0.806 |
| AKI, n (%) | 15 (71.4) | 25 (71.4) | 1.000 |
| RRT, n (%) | 10 (47.6) | 8 (22.9) | 0.055 |
| HF – heart failure; HT – heart transplantation; SD – standard deviation; IQR – interquartile range; HTN – hypertension; DM – diabetes mellitus; CAD – coronary artery disease; MI – myocardial infarction; DCMP – delated cardiomyopathy; ICMP – ischemic cardiomyopathy; LVEF – left ventricular ejection fraction; Cr – creatinine; CKD-EPI eGFR – chronic kidney disease epidemiology collaboration estimated glomerular filtration rate; ECMO – extracorporeal membrane oxygenation, AKI – acute kidney injury; RRT – renal replacement therapy. * If the patient required RRT, serum Cr and CKD-EPI eGFR were assessed immediately prior to RRT initiation. | |||